Placebo
LB.02.01/VII/581/KEP058/2021
Phase 3 small_molecule completed
Quick answer
Placebo for Congenital Heart Disease in Children is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Congenital Heart Disease in Children
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed